Lophius Biosciences Achieves Development Milestone in Establishing High-Performance Tuberculosis Infection Detection Test
Lophius Biosciences GmbH today announced that the company has achieved an important development milestone for its proprietary, blood-based, multi-marker tuberculosis (TB) infection detection assay. During a clinical study, Lophius’ novel test system outperformed predefined performance goals for detecting the presence Mehr




